Volmar CH

Volmar CH

University of Miami

H-index: 24

North America-United States

About Volmar CH

Volmar CH, With an exceptional h-index of 24 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Miami, specializes in the field of Drug Discovery, Alzheimer's Disease, Lysosomal Storage Diseases, Neuroscience, Learning and Memory.

His recent articles reflect a diverse array of research interests and contributions to the field:

Identifying class 1 HDACs as a vulnerability for aggressive uveal melanoma

Diversifying the breast cancer cell line repository with ACRJ-BC24, ACRJ-BC24α, and ACRJ-BC24β: Novel TNBC cell lines derived from an Afro-Caribbean patient

Combination drug screen identifies novel epigenetic therapies to enhance menin inhibitor efficacy in KMT2A rearranged and NPM1 mutant AML

Amplifying gene expression with RNA-targeted therapeutics

A new strategy for Alzheimer’s disease: low‐dose combination of radiotherapy and pharmacological epigenetic perturbation

Transcriptomics for clinical and experimental biology research: hang on a seq

Long non-coding RNA-targeting therapeutics: discovery and development update

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse

Volmar CH Information

University

Position

Center for Therapeutic Innovation Dept. of Psychiatry & Behavioral Sciences

Citations(all)

2216

Citations(since 2020)

1326

Cited By

1404

hIndex(all)

24

hIndex(since 2020)

19

i10Index(all)

37

i10Index(since 2020)

25

Email

University Profile Page

Google Scholar

Volmar CH Skills & Research Interests

Drug Discovery

Alzheimer's Disease

Lysosomal Storage Diseases

Neuroscience

Learning and Memory

Top articles of Volmar CH

Title

Journal

Author(s)

Publication Date

Identifying class 1 HDACs as a vulnerability for aggressive uveal melanoma

Cancer Research

Gulum Yenisehirli

Ashley Zuniga

Sara Rodriguez

Emily V Adis

Gabriela Quintana

...

2024/3/22

Diversifying the breast cancer cell line repository with ACRJ-BC24, ACRJ-BC24α, and ACRJ-BC24β: Novel TNBC cell lines derived from an Afro-Caribbean patient

Cancer Research

Isabella Allen

Shannique Clarke

Jovanka Ravix

Alex P Sanchez Covarrubias

Ayodele Omotoso

...

2024/3/22

Combination drug screen identifies novel epigenetic therapies to enhance menin inhibitor efficacy in KMT2A rearranged and NPM1 mutant AML

Cancer Research

Tulasigeri M Totiger

Sana Chaudhry

Skye Montoya

Maurizio Affer

Anya K Sondhi

...

2024/3/22

Amplifying gene expression with RNA-targeted therapeutics

Olga Khorkova

Jack Stahl

Aswathy Joji

Claude-Henry Volmar

Claes Wahlestedt

2023/7

A new strategy for Alzheimer’s disease: low‐dose combination of radiotherapy and pharmacological epigenetic perturbation

Alzheimer's & Dementia

Claude‐Henry Volmar

Natalie R Ricciardi

Farzaneh Modarresi

Ines Lohse

Nadja S Andrade

...

2023/12

Transcriptomics for clinical and experimental biology research: hang on a seq

Tanner Stokes

Haoning Howard Cen

Philipp Kapranov

Iain J Gallagher

Andrew A Pitsillides

...

2023/6

Long non-coding RNA-targeting therapeutics: discovery and development update

Olga Khorkova

Jack Stahl

Aswathy Joji

Claude-Henry Volmar

Zane Zeier

...

2023/9/2

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse

Biomolecules

Jessica Dennison

Armando Mendez

Angela Szeto

Ines Lohse

Claes Wahlestedt

...

2023/8/29

Nucleic acid-based therapeutics for the treatment of central nervous system disorders

Robyn McCartan

Olga Khorkova

Claude-Henry Volmar

Claes Wahlestedt

2023/8/16

Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease

Roshni C Lalwani

Claude-Henry Volmar

Claes Wahlestedt

Keith A Webster

Lina A Shehadeh

2023/12/6

Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models

Molecular neurobiology

Natalie R Ricciardi

Farzaneh Modarresi

Ines Lohse

Nadja S Andrade

Ian R Newman

...

2023/8

Selective RNA‐targeting of mTORC1 and 2 to ameliorate Alzheimer’s Disease pathogenesis

Alzheimer's & Dementia

Jack Stahl

Aswathy Joji

Olga Khorkova

Claude‐Henry Volmar

Claes Wahlestedt

2023/12

Development of formulated resveratrol (micellar resveratrol) as a small molecule treatment for MPS I

Molecular Genetics and Metabolism

Shaun Brothers

Claude-Henry Volmar

Nancy T Chee

Claes Wahlestedt

Marshall Hayward

2022/2/1

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

Elife

James A Timmons

Andrew Anighoro

Robert J Brogan

Jack Stahl

Claes Wahlestedt

...

2022/1/17

JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model (vol 86, pg 173, 2022)

Journal of Alzheimer's disease

Jessica L Dennison

Claude-Henry Volmar

Farzaneh Modarresi

Danbing Ke

James Wang

...

2022/1/1

Natural antisense transcripts as drug targets

Frontiers in Molecular Biosciences

Olga Khorkova

Jack Stahl

Aswathy Joji

Claude-Henry Volmar

Zane Zeier

...

2022/9/27

Functional drug screening of small molecule inhibitors of epigenetic modifiers in refractory AML patients

Cancers

Jessica L Dennison

Hassan Al-Ali

Claude-Henry Volmar

Shaun Brothers

Justin Watts

...

2022/8/24

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM)

AAPS open

Christopher Kemper

Dariush Behnam

Shaun Brothers

Claes Wahlestedt

Claude-Henry Volmar

...

2022/6/30

Methods for Treating Mucopolysaccharidosis

2021/1/14

Sexual dimorphism in the 3xTg-AD mouse model and its impact on pre-clinical research

Jessica L Dennison

Natalie R Ricciardi

Ines Lohse

Claude-Henry Volmar

Claes Wahlestedt

2021/1/1

See List of Professors in Volmar CH University(University of Miami)